Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-MIBG combinations in relapsed/refractory neuroblastoma
NCT02035137Phase 2Completed
- Sponsor
- New Advances in Neuroblastoma Therapy
- Start
- Jul 2014
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Iobenguane I-131 in neuroblastoma, sponsored by New Advances in Neuroblastoma Therapy. Started Jul 2014; status: completed.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02035137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035137.